Max Petersson

3.2k total citations
32 papers, 2.7k citations indexed

About

Max Petersson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Max Petersson has authored 32 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Max Petersson's work include Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (16 papers). Max Petersson is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (16 papers). Max Petersson collaborates with scholars based in Sweden, United States and Japan. Max Petersson's co-authors include Rolf Kiessling, Koji Kono, Masanori Matsuda, Giuseppe Masucci, Flavio Salazar‐Onfray, Ken Wasserman, Pavel Pisa, Paul Anderson, I Magnusson and Jean‐Luc Taupin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Max Petersson

32 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Petersson Sweden	24	2.2k	947	647	207	195	32	2.7k
Hung‐Sia Teh Canada	32	2.1k 1.0×	485 0.5×	502 0.8×	189 0.9×	199 1.0×	72	2.8k
Pierre Eid France	24	1.4k 0.7×	712 0.8×	548 0.8×	434 2.1×	94 0.5×	47	2.4k
Arie C. Voordouw Netherlands	17	996 0.5×	965 1.0×	525 0.8×	221 1.1×	151 0.8×	20	2.1k
Leslie M. McEvoy United States	17	1.6k 0.7×	557 0.6×	360 0.6×	139 0.7×	122 0.6×	19	2.3k
Kazuhiro Motoki Japan	21	3.5k 1.6×	769 0.8×	954 1.5×	299 1.4×	107 0.5×	41	4.2k
Charles S. Tannenbaum United States	32	1.8k 0.8×	1.2k 1.3×	976 1.5×	139 0.7×	84 0.4×	59	2.9k
Jane S.A. Voerman Netherlands	19	2.3k 1.1×	503 0.5×	670 1.0×	192 0.9×	82 0.4×	35	3.3k
Paul Life United Kingdom	27	1.3k 0.6×	368 0.4×	669 1.0×	203 1.0×	244 1.3×	42	2.6k
J M Depper United States	20	2.5k 1.1×	567 0.6×	830 1.3×	195 0.9×	462 2.4×	25	3.5k
Ángel M. García‐Lora Spain	27	1.6k 0.7×	1.2k 1.3×	699 1.1×	125 0.6×	103 0.5×	57	2.5k

Countries citing papers authored by Max Petersson

Since Specialization

Citations

This map shows the geographic impact of Max Petersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Petersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Petersson more than expected).

Fields of papers citing papers by Max Petersson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Petersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Petersson. The network helps show where Max Petersson may publish in the future.

Co-authorship network of co-authors of Max Petersson

This figure shows the co-authorship network connecting the top 25 collaborators of Max Petersson. A scholar is included among the top collaborators of Max Petersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Petersson. Max Petersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salazar‐Onfray, Flavio, Mercedes López, Andreas Lundqvist, et al.. (2002). Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. British Journal of Cancer. 87(4). 414–422. 98 indexed citations

Petersson, Max, et al.. (2002). Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses. Cancer Immunology Immunotherapy. 51(3). 163–170. 28 indexed citations

Malmberg, Karl‐Johan, Velmurugesan Arulampalam, Fumiko Ichihara, et al.. (2001). Inhibition of Activated/Memory (CD45RO+) T Cells by Oxidative Stress Associated with Block of NF-κB Activation. The Journal of Immunology. 167(5). 2595–2601. 121 indexed citations

Sandberg, Johan K., Lars Franksson, Jonas Sundbäck, et al.. (2000). T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity. The Journal of Immunology. 165(1). 25–33. 63 indexed citations

Kiessling, Rolf, Ken Wasserman, S. Horiguchi, et al.. (1999). Tumor-induced immune dysfunction. Cancer Immunology Immunotherapy. 48(7). 353–362. 194 indexed citations

Yang, Rongcun, Flavio Salazar‐Onfray, Jehad Charo, et al.. (1999). Identification of New HER2/ neu- Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas. The Journal of Immunology. 163(2). 1037–1044. 153 indexed citations

Nieland, John D., Koji Kono, Kathy S. Albain, et al.. (1998). PBLs of Early Breast Carcinoma Patients with a High Nuclear Grade Tumor Unlike PBLs of Cervical Carcinoma Patients Do Not Show a Decreased TCRξ Expression but Are Functionally Impaired. Journal of Immunotherapy. 21(4). 317–317. 16 indexed citations

Petersson, Max, Carey L. O’Donnell, Kevin P. Williams, et al.. (1998). Immunization with a Lymphocytic Choriomeningitis Virus Peptide Mixed with Heat Shock Protein 70 Results in Protective Antiviral Immunity and Specific Cytotoxic T Lymphocytes. The Journal of Experimental Medicine. 187(5). 685–691. 159 indexed citations

Masucci, Giuseppe, Anna Svensson, Mona Hansson, et al.. (1997). Efficient Harvest of In Vivo IL-2-Activated CD3+ Lymphocytes for Adoptive Immunotherapy by Selective Leukapheresis (Lymphocytapheresis). Journal of Hematotherapy. 6(3). 253–260. 7 indexed citations

10.

Halapi, Eva, Christina Hising, Max Petersson, et al.. (1997). Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/NEU proto-oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression. International Journal of Cancer. 70(1). 112–119. 30 indexed citations

11.

Salazar‐Onfray, Flavio, Jehad Charo, Max Petersson, et al.. (1997). Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. The Journal of Immunology. 159(7). 3195–3202. 75 indexed citations

12.

Kono, Koji, Flavio Salazar‐Onfray, Max Petersson, et al.. (1996). Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity. European Journal of Immunology. 26(6). 1308–1313. 301 indexed citations

13.

Kiessling, Rolf, Koji Kono, Max Petersson, & Ken Wasserman. (1996). Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules. Springer Seminars in Immunopathology. 18(2). 227–242. 40 indexed citations

14.

Petersson, Max, Alvar Grönberg, Rolf Kiessling, & Mats Ferm. (1995). Engagement of MHC Class I Proteins on Natural Killer Cells Inhibits their Killing Capacity. Scandinavian Journal of Immunology. 42(1). 34–38. 7 indexed citations

15.

Matsuda, Masanori, Max Petersson, Rodiça Lenkei, et al.. (1995). Alterations in the signal‐transducing molecules of T cells and nk cells in colorectal tumor‐infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease. International Journal of Cancer. 61(6). 765–772. 181 indexed citations

16.

Matsuda, Masanori, Max Petersson, Giuseppe Masucci, et al.. (1994). Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.. The Journal of Experimental Medicine. 180(6). 2371–2376. 263 indexed citations

17.

Grönberg, Alvar, Eva Halapi, Mats Ferm, Max Petersson, & Manuel E. Patarroyo. (1993). Regulation of Lymphocyte Aggregation and Proliferation through Adhesion Molecule GD54 (ICAM-1). Cellular Immunology. 147(1). 12–24. 8 indexed citations

18.

Franksson, Lars, Max Petersson, Rolf Kiessling, & Klas Kärre. (1993). Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. European Journal of Immunology. 23(10). 2606–2613. 33 indexed citations

19.

Hansson, Mona, Max Petersson, Gloria C. Koo, Hans Wigzell, & Rolf Kiessling. (1988). In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen. European Journal of Immunology. 18(3). 485–488. 37 indexed citations

20.

Klein, Gerd, et al.. (1988). Effects of Dimethyl Sulfoxide Treatment on H-2 Expression and Susceptibility to NK-- or Cytotoxic T--Lymphocyte-Mediated Lysis of the YAC-1 Lymphoma and Its beta2--Microglobulin--Deficient Variant1. JNCI Journal of the National Cancer Institute. 80(4). 263–269. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact